on Clinical Outcomes of Platinum-Based Chemotherapy for Chinese Non-Small Cell Lung Cancer Patients
- Wu Wenting
- Li Huan
- Wang Huibo
- Zhao Xueying
- Gao Zhiqiang
- Qiao Rong
- Zhang Wei
- Qian Ji
- Wang Jiucun
- Chen Hongyan
- Wei Qingyi
- Han Baohui
- Lu Daru
DOIAbstract
polymorphisms affect clinical efficacy among advanced non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy.) were genotyped by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry or PCR-based sequencing. were also observed among patients with performance status of 0–1 and patients with adenocarcinoma. However, no significant associations were found between these polymorphisms, chemotherapy response and PFS. polymorphisms/haplotype on NSCLC prognosis in inoperable advanced NSCLC patients treated with platinum-based chemotherapy
Add to ORKG